Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM in Patients With Septic Shock
Status:
Completed
Trial end date:
2018-06-13
Target enrollment:
Participant gender:
Summary
This is a randomised, double-blind, two-stage, placebo controlled study. It is designed to
investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of 3 doses of
MOTREM versus placebo in adult patients with septic shock.